Das Universitätsklinikum Köln ist ein Krankenhaus der Maximalversorgung und übernimmt gesellschaftliche Aufgaben in Forschung, Lehre und Krankenversorgung. Der Klinikcampus liegt im Kölner Stadtteil Lindenthal.

During the past decade, University Hospital of Cologne conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 12 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 7 clinical trials were completed. i.e. 13% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of Cologne" #1 sponsor was "University of Cologne" with 48 trials, followed by "Universitätsklinikum Köln" with 14 trials sponsored, "University Hospital of Cologne" with 13 trials sponsored, "Heidelberg University" with 5 trials sponsored and "German CLL Study Group" with 5 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Cologne" #1 collaborator was "University Hospital of Cologne" with 6 trials as a collaborator, "Boehringer Ingelheim" with 4 trials as a collaborator, "German Federal Ministry of Education and Research" with 3 trials as a collaborator, "University Hospital Lübeck" with 3 trials as a collaborator and "ZKS Köln" with 3 trials as a collaborator. Other collaborators include 171 different institutions and companies that were collaborators in the rest 168 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Cologne" are "Heart Failure" (4 trials), "Invasive Aspergillosis" (4 trials), "COVID-19" (3 trials), "Cardiac Arrest" (3 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "University Hospital of Cologne" in a lesser frequency.

Most popular intervention types in "University Hospital of Cologne" are "Drug" (51 trials), "Other" (32 trials), "Device" (19 trials), "Procedure" (13 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "no intervention" (4 trials), "Cyclophosphamide" (3 trials), "Conventional physiotherapy" (2 trials) and "DZIF-10c" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Cologne" are 151 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 55 active trials in "University Hospital of Cologne". 5 are not yet recruiting, 34 are recruiting, 14 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 68 completed trials in University Hospital of Cologne, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Cologne, 11 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 29 trials that are defined as “Not Applicable".